These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8356888

  • 1. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 2. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P, Catapano F, Tortorella A, Maj M.
    Neuropsychobiology; 1997 Jun; 36(1):8-12. PubMed ID: 9211437
    [Abstract] [Full Text] [Related]

  • 3. Thyroid axis activity and serotonin function in major depressive episode.
    Duval F, Mokrani MC, Bailey P, Correa H, Diep TS, Crocq MA, Macher JP.
    Psychoneuroendocrinology; 1999 Oct; 24(7):695-712. PubMed ID: 10451906
    [Abstract] [Full Text] [Related]

  • 4. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 5. TRH stimulation test in obsessive-compulsive patients.
    Aizenberg D, Hermesh H, Gil-ad I, Munitz H, Tyano S, Laron Z, Weizman A.
    Psychiatry Res; 1991 Jul; 38(1):21-6. PubMed ID: 1946831
    [Abstract] [Full Text] [Related]

  • 6. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK.
    Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964
    [Abstract] [Full Text] [Related]

  • 7. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Martin K, Berman S, Csernansky JG.
    Psychiatry Res; 1992 Apr 01; 42(1):81-92. PubMed ID: 1603884
    [Abstract] [Full Text] [Related]

  • 8. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 01; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 9. Reduced prolactin response to fenfluramine challenge in personality disorder patients is not due to deficiency of pituitary lactotrophs.
    Coccaro EF, Klar H, Siever LJ.
    Biol Psychiatry; 1994 Sep 01; 36(5):344-6. PubMed ID: 7993962
    [No Abstract] [Full Text] [Related]

  • 10. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb 01; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 11. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):177-85. PubMed ID: 3337615
    [Abstract] [Full Text] [Related]

  • 12. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P, Catapano F, Bortolotti F, Maj M.
    Biol Psychiatry; 1997 Aug 01; 42(3):175-80. PubMed ID: 9232209
    [Abstract] [Full Text] [Related]

  • 13. Dose-response studies with protirelin.
    Garbutt JC, Mayo JP, Little KY, Gillette GM, Mason GA, Dew B, Prange AJ.
    Arch Gen Psychiatry; 1994 Nov 01; 51(11):875-83. PubMed ID: 7944876
    [Abstract] [Full Text] [Related]

  • 14. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT, Hanna GL.
    J Child Adolesc Psychopharmacol; 2005 Aug 01; 15(4):581-7. PubMed ID: 16190790
    [Abstract] [Full Text] [Related]

  • 15. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA, Roberts A, Montgomery SA, Cowen PJ.
    Br J Psychiatry; 1997 Sep 01; 171():280-2. PubMed ID: 9337985
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM, O'Keane V, Murray RM.
    Br J Psychiatry; 1996 Jan 01; 168(1):57-60. PubMed ID: 8770429
    [Abstract] [Full Text] [Related]

  • 17. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug 01; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine.
    Judd FK, Apostolopoulos M, Burrows GD, Norman TR.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar 01; 18(2):329-37. PubMed ID: 8208982
    [Abstract] [Full Text] [Related]

  • 19. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Mar 01; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 20. HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls.
    Maes M, D'Hondt P, Suy E, Minner B, Vandervorst C, Raus J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1991 Mar 01; 15(6):781-90. PubMed ID: 1662403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.